Ligand validation:3UTG

FDA: DIHYDROFLAVINE-ADENINE DINUCLEOTIDE

FDA is a Ligand Of Interest in 3UTG designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3UTG_FDA_B_511	81%	12%	0.11	0.961	2.69	1.54	22	9	0	0	100%	1
3UTG_FDA_D_511	80%	11%	0.115	0.964	2.72	1.61	21	11	0	0	100%	1
3UTG_FDA_A_511	79%	12%	0.115	0.961	2.66	1.58	21	11	0	0	100%	1
3UTG_FDA_C_511	78%	12%	0.113	0.957	2.73	1.57	22	11	0	0	100%	1
4U8P_FDA_B_601	93%	13%	0.086	0.98	2.5	1.64	19	10	0	0	100%	1
3UTF_FDA_B_511	86%	12%	0.106	0.975	2.69	1.59	25	9	0	0	100%	1
4U8O_FDA_B_601	85%	12%	0.119	0.984	2.73	1.57	22	9	0	0	100%	1
4WX1_FDA_C_601	84%	11%	0.104	0.968	2.7	1.63	24	10	0	0	100%	1
3UTH_FDA_B_511	84%	12%	0.108	0.972	2.66	1.64	23	10	0	0	100%	1
3TSH_FDA_A_601	100%	40%	0.04	0.992	1.03	1.38	3	6	3	0	100%	1
7AA2_FDA_A_701	100%	60%	0.043	0.986	0.69	0.83	-	1	3	0	100%	1
6ZE6_FDA_A_701	99%	60%	0.044	0.984	0.72	0.8	-	1	3	0	100%	1
4U2S_FDA_A_605	99%	16%	0.064	0.997	1.76	2.08	9	9	5	0	100%	1
6ZE2_FDA_B_701	99%	59%	0.048	0.979	0.71	0.83	-	1	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.